Interactions between canine RAD51 and full length or truncated BRCA2 BRC repeats

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Mutations in the breast cancer susceptibility protein 2 (BRCA2) gene are linked to increased cancer risk.
• The BRCA2 protein interacts with the recombinase RAD51, crucial for DNA repair.
• This interaction is mediated by eight BRC repeat sequences within the BRCA2 protein.

Purpose of the Study:

• To investigate the binding affinities of individual BRC repeats within the BRCA2 protein to RAD51.
• To understand how alterations in BRC repeat sequences affect BRCA2-RAD51 interactions.
• To provide insights into the impact of BRCA2 mutations on cancer development, particularly in canine tumors.

Main Methods:

• Mammalian two-hybrid assays were employed to assess the binding of individual BRC repeats to RAD51.
• Serial deletion mutation experiments were conducted to evaluate the effect of removing C-terminal BRC repeats on binding strength.

Main Results:

• BRC repeat 6 (BRC6) showed no binding to RAD51.
• BRC1, BRC2, and BRC4 exhibited strong binding to RAD51.
• BRC8 demonstrated intermediate binding, while BRC3, BRC5, and BRC7 showed weak binding. Deletion of the C-terminal BRC repeat enhanced binding in several constructs.

Conclusions:

• The study elucidates the differential binding capabilities of BRCA2 BRC repeats to RAD51.
• Findings suggest that the specific BRC repeat involved in a mutation influences the functional consequence of the mutation.
• These results may inform the understanding of missense and truncation mutations in BRCA2, relevant to both human and canine cancers.